Core Insights - The article highlights the performance of top private equity founders in the past six months, showcasing their investment strategies and product performance [2][4]. Group 1: Performance Overview - As of October 24, 2025, 25 private equity founders had over 10 products each that met ranking criteria, with a total of 432 products and a combined scale of approximately 71.11 billion yuan, achieving an average return of 22.86% [2]. - The top 10 private equity founders based on performance include: Dan Bin from Dongfang Gangwan, Wang Wen from Rido Investment, Xie Xiaoyang from Tianyan Capital, Gao Simeng from Jukuan Investment, Liang Yong from Haiziyuan Investment, Zhu Xiaokang from Longqi Technology, Liang Hong from Hainan Xiwa, Zou Yitian from Heiyi Asset, Lin Ziyang from Hainan Shengfeng Private Equity, and Gao Kang from Yanfu Investment [2][3]. Group 2: Individual Founder Insights - **Dongfang Gangwan (Dan Bin)**: Managed 69 products with a total scale of approximately 10.02 billion yuan, achieving an average return of ***% in the past six months, leading the rankings [5][7]. - **Rido Investment (Wang Wen)**: Managed 18 products with a total scale of approximately 13.68 billion yuan, with most products achieving returns above ***%, ranking second [8][9]. - **Tianyan Capital (Xie Xiaoyang)**: Managed 12 products with a total scale of approximately 2.25 billion yuan, primarily focusing on quantitative stock selection, with returns above ***% [10]. - **Jukuan Investment (Gao Simeng)**: Managed 42 products with a total scale of approximately 3.38 billion yuan, achieving an average return of ***% [11]. - **Haiziyuan Investment (Liang Yong)**: Managed 11 products with a total scale of approximately 1.27 billion yuan, ranking fifth with an average return of ***% [13]. - **Longqi Technology (Zhu Xiaokang)**: Managed 16 products with a total scale of approximately 2.66 billion yuan, achieving an average return of ***% [16]. - **Hainan Xiwa (Liang Hong)**: Managed 23 products with a total scale of approximately 4.51 billion yuan, with most products achieving returns above ***% [18]. - **Heiyi Asset (Zou Yitian)**: Managed 19 products with a total scale of approximately 2.36 billion yuan, achieving an average return of ***% [20]. - **Hainan Shengfeng Private Equity (Lin Ziyang)**: Managed 12 products with a total scale of approximately 2.33 billion yuan, ranking ninth with an average return of ***% [24].

本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看专栏 ） 编者语： 知名基金经理往往会受到更多关注，私募排排网特此成立了 #基金经理人物志 # 专栏。未来，我们还将以系列内容更新，同时也欢迎广大读者留言告知您所感 兴趣的基金大佬，我们将不定期为大家更新这些传奇大佬的从业经历、最新持仓、投资理念等内容。本期介绍嘉宾： 百亿 私募希瓦梁宏 。 目录导览 01、 前言 02、 从美股交易员到"实业亏光"的跨界玩家 在私募基金的江湖里，梁宏是一个无法被忽略的名字。他没有显赫的科班背景，也没有传统金融机构的镀金光环，却凭借对市场的敏锐嗅觉、敢 言敢做的鲜明风格，以及一条标志性的大金链子，硬生生在百亿级的私募战场上杀出了一条"野生"之路。 从美股交易员到实业试水失败，从雪球 大V到私募掌门人，他的成长轨迹充满了草根的韧性与江湖的彪悍。 这是一个关于梦想、逆袭、争议与坚持的故事，也是一个中国私募生态中的 独特样本。 从美股交易员到"实业亏光"的跨界玩家 梁宏毕业于上海交通大学，2001年迈出校园后，他从事过财务软件咨询工作。但很快，他就投身到美股交易员的行列中。那时的他，或许未曾料 到，这段美股交易经历，会为他开启一 ...

Core Viewpoint - The A-share market has shown a strong performance, with the Shanghai Composite Index reaching 3700 points, indicating a recovery from previous economic shocks. A trend of gradual growth has emerged since April 27, following the impact of U.S. tariffs, leading to a widening gap between stock strategies and other primary strategies [1]. Summary by Categories Market Performance - The A-share market has entered a four-month trend of gradual growth, with a noticeable recovery in the index [1]. - Quantitative long strategies and subjective long strategies have both performed well, with quantitative long strategies achieving a return of 25.02% and subjective long strategies averaging 5.86% in July [3][4]. Strategy Performance - Among various strategies, subjective long strategies have outperformed quantitative long strategies due to their concentrated positions and flexibility in trading [4]. - The average return for subjective long strategies across different scales of private equity funds has been significant, with the highest returns observed in the 10-20 billion category at 25.43% [18]. Fund Performance - The top-performing subjective long products in the 100 billion category include "和谐汇一医疗创新B类份额" managed by 施跃, achieving a return of ***% [7][5]. - In the 50-100 billion category, "同犇22期" managed by 童驯 led with a return of ***% [14]. - The 20-50 billion category saw "丹羿鹏程1号1期" managed by 王帅 achieving a return of ***% [17]. - In the 10-20 billion category, "能敬价值优选二号" managed by 孙杰 led with a return of ***% [21]. - The 5-10 billion category was topped by "优波三号A类份额" managed by 陈龙 with a return of ***% [24]. - The 0-5 billion category saw "子衿云杉" managed by 邹凯 achieving a return of ***% [28]. Investment Insights - Fund managers are focusing on sectors such as innovative pharmaceuticals and medical devices, indicating a re-evaluation of high-quality assets in China [8]. - The market is currently in a phase where investors are cautious about the sustainability of earnings for companies that have seen significant price increases [8].